The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Our translational research program aims to leverage our expertise in genetic therapies and personalized medicine to develop clinical solutions that target the molecular causes of human diseases.
The Department of Genetic Medicine advances treatments and diagnostics through diverse clinical trials, including drug testing and research to better understand diseases.
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Our translational research program aims to leverage our expertise in genetic therapies and personalized medicine to develop clinical solutions that target the molecular causes of human diseases.
The Department of Genetic Medicine advances treatments and diagnostics through diverse clinical trials, including drug testing and research to better understand diseases.
Find details regarding staff and academic career opportunities available within the Department of Genetic Medicine at Weill Cornell.
Current Opportunities
|
The Laboratory of Ronald G. Crystal, MD, at Weill Cornell Medicine in New York City is recruiting postdoctoral scientists for projects related to gene therapy. The Department conducts a broad range of gene therapy projects from the bench to the clinic including production of GMP vectors for clinical trials. Projects include proof-of-concept models for development of new therapeutic strategies, pre-clinical data generation for regulatory filings, and clinical trial data acquisition and analysis. Projects related to GMP vector production are also available. Current pre-clinical and clinical gene therapy targets include the use of AAV- or adenovirus-mediated gene transfer to the CNS or systemic circulation for the treatment of Alzheimer’s Disease and other tauopathies, alpha-1 antitrypsin deficiency, Friedreich’s ataxia, eosinophilic esophagitis, aldehyde dehydrogenase 2 deficiency, oxidative stress-related diseases, vaccines to treat addiction, and enhancement of reconstructive plastic and orthopedic surgery. In addition, the lab is actively developing next-generation gene therapy tools and methods of analysis including gene editing, improved gene expression cassettes, gene expression control systems, genome-wide analysis to evaluate on- and off-target vector effects, and positron-emission tomography to track the fate of gene therapy vectors after delivery. We are looking for post-doctoral fellows with energy and new ideas who can take advantage of our extensive infrastructure to advance the field of gene therapy. Candidates must hold a doctoral degree (PhD, MD or equivalent) in a field related to gene therapy.
To apply: email your cover letter and CV to geneticmedicine@med.cornell.edu; including “Gene Therapy Postdoc” in the subject line. Candidates are not required to have experience in gene therapy, but should demonstrate productivity through high quality, first author publications in a related field. Weill Cornell Medicine is an Equal Opportunity Employer. Women and underrepresented applicants are especially encouraged to apply.
The Belfer Gene Therapy Core Facility of the Department of Genetic Medicine at Weill Cornell Medicine is hiring a Good Manufacturing Practices (GMP) Technician I. The GMP Technician I will be responsible for manufacturing and performing quality control (QC) tests of gene therapy products in compliance with the quality system established by the Belfer Gene Therapy Core Facility and the FDA and/or EU Good Manufacturing Practice Standards for early drug development phase. Please visit this posting on the Weill Cornell jobs site here.